184 related articles for article (PubMed ID: 33199176)
1. Results of accelerated partial breast irradiation in patients not suitable for external beam irradiation stratified by GEC-ESTRO, ASTRO, and ABS guidelines.
Campos Magalhães Garcia LS; Garcia Trigo ML
Brachytherapy; 2021; 20(2):315-325. PubMed ID: 33199176
[TBL] [Abstract][Full Text] [Related]
2. A comparison of long-term clinical outcomes of accelerated partial breast irradiation using interstitial brachytherapy as per GEC-ESTRO, ASTRO, updated ASTRO, and ABS guidelines.
Budrukkar A; Telkhade T; Wadasadawala T; Shet T; Upreti RR; Jalali R; Badwe R; Gupta S; Sarin R
Brachytherapy; 2020; 19(3):337-347. PubMed ID: 32359677
[TBL] [Abstract][Full Text] [Related]
3. Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy.
Mills MN; Russo NW; Fahey M; Nanda RH; Raiker S; Jastrzebski J; Stout LL; Wilson JP; Altoos TA; Allen KG; Blumencranz PW; Diaz R
Oncologist; 2021 Nov; 26(11):e1931-e1938. PubMed ID: 34516030
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean Breast Cancer Patients (KROG 22-15).
Chun SJ; Jo JH; Kim YB; Park S; Ahn SJ; Kim SS; Kim K; Shin KH
Cancer Res Treat; 2024 Apr; 56(2):549-556. PubMed ID: 38062705
[TBL] [Abstract][Full Text] [Related]
6.
Hannoun-Levi JM; Chamorey E; Boulahssass R; Polgar C; Strnad V;
Clin Transl Radiat Oncol; 2021 Jul; 29():1-8. PubMed ID: 33997321
[TBL] [Abstract][Full Text] [Related]
7. Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion.
Mills MN; Russo NW; Nanda RH; Wilson JP; Altoos TA; Caldwell DL; Stout LL; Dube S; Blumencranz PW; Allen KG; Diaz R
Brachytherapy; 2021; 20(2):345-352. PubMed ID: 33317964
[TBL] [Abstract][Full Text] [Related]
8. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
[TBL] [Abstract][Full Text] [Related]
9. Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor Analysis.
Hannoun-Levi JM; Gal J; Polgar C; Strnad V; Loessl K; Polat B; Kauer-Domer D; Schiappa R; Gutierrez C
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1200-1210. PubMed ID: 37459998
[TBL] [Abstract][Full Text] [Related]
10. Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort.
Wadasadawala T; Mondal M; Paul SN; Parmar V; Nair N; Shet T; Desai S; Gupta S; Sarin R
J Contemp Brachytherapy; 2018 Feb; 10(1):47-57. PubMed ID: 29619056
[TBL] [Abstract][Full Text] [Related]
11. SHARE: a French multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence.
Belkacemi Y; Bourgier C; Kramar A; Auzac G; Dumas I; Lacornerie T; Mége JP; Mijonnet S; Lemonnier J; Lartigau E
Clin Adv Hematol Oncol; 2013 Feb; 11(2):76-83. PubMed ID: 23598908
[TBL] [Abstract][Full Text] [Related]
12. Five-year results of accelerated partial breast irradiation: A single-institution retrospective review of 289 cases.
Laplana M; Cozzi S; Najjari D; Martín MI; Rodríguez G; Slocker A; Sancho I; Pla MJ; García M; Gracia R; Pera J; Guedea F; Gutiérrez C
Brachytherapy; 2021; 20(4):807-817. PubMed ID: 33810984
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
[TBL] [Abstract][Full Text] [Related]
14. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).
Polgár C; Van Limbergen E; Pötter R; Kovács G; Polo A; Lyczek J; Hildebrandt G; Niehoff P; Guinot JL; Guedea F; Johansson B; Ott OJ; Major T; Strnad V;
Radiother Oncol; 2010 Mar; 94(3):264-73. PubMed ID: 20181402
[TBL] [Abstract][Full Text] [Related]
15. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
16. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.
Strnad V; Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Łyczek J; Guinot JL; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Fietkau R; Schlamann A; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Dunst J; Gall C; Uter W;
Lancet Oncol; 2023 Mar; 24(3):262-272. PubMed ID: 36738756
[TBL] [Abstract][Full Text] [Related]
17. Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base.
Shaitelman SF; Lin HY; Smith BD; Shen Y; Bedrosian I; Marsh GD; Bloom ES; Vicini FA; Buchholz TA; Babiera GV
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):338-48. PubMed ID: 26853342
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.
Wilkinson JB; Beitsch PD; Shah C; Arthur D; Haffty BG; Wazer DE; Keisch M; Shaitelman SF; Lyden M; Chen PY; Vicini FA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1179-85. PubMed ID: 23182700
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy for partial breast irradiation: the European experience.
Polgár C; Strnad V; Major T
Semin Radiat Oncol; 2005 Apr; 15(2):116-22. PubMed ID: 15809937
[TBL] [Abstract][Full Text] [Related]
20. Recurrence rates for patients with early-stage breast cancer treated with IOERT at a community hospital per the ASTRO consensus statement for APBI.
Williams VL; Bhandari T; Chen LJ; Wagman LD; Carpenter M; Harness JK; Khanijou R; Gobran M; Olaya W; Carandang MI; Ash RB
Brachytherapy; 2019; 18(5):651-657. PubMed ID: 31235444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
